Tandem Investment Advisors, Inc. Pfizer Inc Transaction History

Tandem Investment Advisors, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$36.12 - $41.79 $221,668 - $256,465	-6,137 Closed	0 $0
Q1 2023 Jul 18, 2023	BUY	$39.39 - $51.28 $64,875 - $84,458	1,647 Added 36.68%	6,137 $250,000
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $187,457 - $244,705	4,490 New	4,490 $230,000
Q2 2022 Sep 14, 2022	SELL	$46.53 - $55.17 $198,543 - $235,410	-4,267 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $22,783 - $28,231	-498 Reduced 10.45%	4,267 $221,000
Q4 2021 Jan 20, 2022	SELL	$41.32 - $61.25 $9,090 - $13,475	-220 Reduced 4.41%	4,765 $281,000
Q3 2021 Oct 15, 2021	SELL	$39.25 - $50.42 $4,906 - $6,302	-125 Reduced 2.45%	4,985 $214,000
Q2 2021 Jul 12, 2021	BUY	$35.91 - $40.68 $183,500 - $207,874	5,110 New	5,110 $200,000
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $159,493 - $206,816	-4,909 Closed	0 $0
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $55,396 - $62,196	-1,498 Reduced 23.38%	4,909 $213,000
Q1 2019 Apr 15, 2019	SELL	$37.5 - $41.2 $133,387 - $146,548	-3,557 Reduced 35.7%	6,407 $272,000
Q4 2018 Jan 25, 2019	BUY	$38.47 - $43.86 $142,454 - $162,413	3,703 Added 59.14%	9,964 $435,000
Q3 2018 Oct 15, 2018	BUY	$34.47 - $41.81 $20,061 - $24,333	582 Added 10.25%	6,261 $276,000
Q2 2018 Jul 05, 2018	SELL	$32.98 - $35.16 $1,055 - $1,125	-32 Reduced 0.56%	5,679 $206,000
Q1 2018 Apr 03, 2018	BUY	$31.91 - $37.02 $702 - $814	22 Added 0.39%	5,711 $203,000
Q4 2017 Jan 09, 2018	BUY	$33.26 - $35.29 $189,216 - $200,764	5,689	5,689 $206,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Tandem Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tandem Investment Advisors, Inc. with notifications on news.